Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

505 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME; REASON Project. Mallion JM, et al. Among authors: duprez d. Am J Hypertens. 2004 Mar;17(3):245-51. doi: 10.1016/j.amjhyper.2003.11.001. Am J Hypertens. 2004. PMID: 15001199 Clinical Trial.
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
de Luca N, Mallion JM, O'Rourke MF, O'Brien E, Rahn KH, Trimarco B, Romero R, De Leeuw PW, Hitzenberger G, Battegay E, Duprez D, Sever P, Safar ME. de Luca N, et al. Among authors: duprez d. Am J Hypertens. 2004 Aug;17(8):660-7. doi: 10.1016/j.amjhyper.2004.03.681. Am J Hypertens. 2004. PMID: 15323062 Clinical Trial.
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
Asmar RG, London GM, O'Rourke ME, Mallion JM, Romero R, Rahn KH, Trimarco B, Fitzgerald D, Hedner T, Duprez D, De Leeuw PW, Sever P, Battegay E, Hitzenberger G, de Luca N, Polónia P, Bénétos A, Chastang C, Ollivier JP, Safar ME; REASON Project Investigators (pREterax in regression of Arterial Stiffness in a contrOlled double-bliNd Study). Asmar RG, et al. Among authors: duprez d. J Hypertens Suppl. 2001 Nov;19(4):S15-20. J Hypertens Suppl. 2001. PMID: 11848258 Clinical Trial.
Determination of arterial compliance using blood pressure waveform analysis with the CR-2000 system: Reliability, repeatability, and establishment of normal values for healthy European population--the seven European sites study (SESS).
Zimlichman R, Shargorodsky M, Boaz M, Duprez D, Rahn KH, Rizzoni D, Payeras AC, Hamm C, McVeigh G. Zimlichman R, et al. Among authors: duprez d. Am J Hypertens. 2005 Jan;18(1):65-71. doi: 10.1016/j.amjhyper.2004.08.013. Am J Hypertens. 2005. PMID: 15691619 Clinical Trial.
Angiotensin II, platelets and oxidative stress.
Duprez DA. Duprez DA. J Hypertens. 2004 Jun;22(6):1085-6. doi: 10.1097/00004872-200406000-00005. J Hypertens. 2004. PMID: 15167439 No abstract available.
505 results